# Artivion Completes Acquisition of Endospan Ltd.
Canonical URL: https://biopharmsignal.com/news/AORT/artivion-completes-acquisition-of-endospan-ltd
Ticker: AORT
Company: Artivion
Source: Artivion
Published: 2026-05-18 11:00 EST
Original Source URL: https://investors.artivion.com
## Summary

ATLANTA, May 18, 2026   Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it has completed the acquisition of its long-standing partner Endospan Ltd. ("Endospan"), a pioneer in the endovascular repair of aortic arch disease 

## Article Body
ATLANTA, May 18, 2026   Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it has completed the acquisition of its long-standing partner Endospan Ltd. ("Endospan"), a pioneer in the endovascular repair of aortic arch disease
## Recent Company News
- 2026-05-18 11:00 EST — [Artivion Completes Acquisition of Endospan Ltd.](https://biopharmsignal.com/news/AORT/artivion-completes-acquisition-of-endospan-ltd) — Source: Artivion
- 2026-05-07 20:05 EST — [Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan](https://biopharmsignal.com/news/AORT/artivion-reports-first-quarter-2026-financial-results-and-announces-exercise-of-option-to-acquire-endospan) — Source: Artivion
- 2026-04-23 20:15 EST — [Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results](https://biopharmsignal.com/news/AORT/artivion-announces-release-date-and-teleconference-call-details-for-first-quarter-2026-financial-results) — Source: Artivion
- 2026-04-07 11:00 EST — [Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System](https://biopharmsignal.com/news/AORT/artivion-announces-u-s-fda-approval-of-the-nexusr-aortic-arch-system) — Source: Artivion
- 2026-03-03 21:10 EST — [Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference](https://biopharmsignal.com/news/AORT/artivion-to-participate-in-the-oppenheimer-36th-annual-healthcare-medtech-and-services-conference) — Source: Artivion
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)